These results indicate that the antitumor effects of h4#147D are attenuated by expression of KLF5 in the MIA PaCa-2 xenograft tumor model, suggesting KLF5 as a potential negative regulator for the antitumor activity of h4#147D. Here, KLF5 is linked to neoplasm.